Company Profile
Precision BioSciences Stock Price, News & Analysis
- Ticker:
- DTIL
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Precision BioSciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
6.95 USD (-1.84%)
Close
Last updated: June 23, 2026 at 00:00
179.33M USD
Market cap
Why the stock is moving
DTIL is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Precision BioSciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Precision BioSciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Precision BioSciences follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Precision BioSciences sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
Source: Precision BioSciences
- 05
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update
Source: Precision BioSciences
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Precision BioSciences (DTIL)?
Precision BioSciences (DTIL) most recently closed at 6.95 USD, a -1.84% move versus the previous session.
What is the market cap of Precision BioSciences (DTIL)?
Precision BioSciences currently has a market capitalization of 179.33M USD on BioPharmSignal.
What does Precision BioSciences do?
Precision BioSciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is DTIL stock listed?
Precision BioSciences (DTIL) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Precision BioSciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Precision?
Precision BioSciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Precision BioSciences targeting with Precision?
Precision BioSciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is BioSciences?
Precision BioSciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.